BC that is linked withgerminal mutations in BRCA1 has a triple negative phenotype(70–85 %), while ER-positive cases can be detected in carriersof mutations in the BRCA2, ATM, CHEK2 and PALB2 genes(Breast Cancer Association Consortium, 2021). This evidence concerns the gene BRCA2 and breast cancer.